Title: SENATE BILL 27 By: Bullard
Official Title: SENATE BILL 27 By: Bullard
Number of Sections: 22
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 11 sections found

================================================================================

Section 1:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to controlled dangerous substances;
7
amending 63 O.S. 2021, Section 2-309, as last amended
8
by Section 6, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
8
2024, Section 2-309), which relates to prescriptions;
9
exempting certain practitioners from electronic
9
prescription requirement; limiting availability of
10
exemption; directing licensing boards to take certain
10
actions; updating statutory language; and providing
11
an effective date.
11
12
12
13
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
13
14

Section 2:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-309, as
14
15
last amended by Section 6, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
15
16
2024, Section 2-309), is amended to read as follows:
16
17

Section 3:
Section 2-309. A. 1. Except for dosages medically required
17
18
for a period not to exceed forty-eight (48) hours which are
18
19
administered by or on direction of a practitioner, other than a
19
20
pharmacist, or medication dispensed directly by a practitioner,
20
21
other than a pharmacist, to an ultimate user, no controlled
21
22
dangerous substance included in Schedule II, which is a prescription
22
23
drug as determined under regulation promulgated by the State Board
23
24
of Pharmacy, shall be dispensed without an electronic prescription
24
Req. No. 130 Page 1
1
of a practitioner; provided, that in emergency situations, as
1
2
prescribed by the State Board of Pharmacy by regulation, such drug
2
3
may be dispensed upon oral prescription reduced promptly to writing
3
4
and filed by the pharmacist in a manner to be prescribed by rules
4
5
and regulations of the Director of the Oklahoma State Bureau of
5
6
Narcotics and Dangerous Drugs Control.
6
7

Section 4:
2. Electronic prescribing shall be utilized for Schedules II,
7
8
III, IV and V, subject to the requirements set forth in 21 CFR,
8
9

Section 5:
Section 1311 et seq.
9
10

Section 6:
3. An electronic prescription with electronic signature may
10
11
serve as an original prescription, subject to the requirements set
11
12
forth in 21 CFR, Section 1311 et seq.
12
13

Section 7:
4. Prescriptions shall be retained in conformity with the
13
14
requirements of this section and Section 2-307 of this title. No
14
15
prescription for a Schedule II substance may be refilled.
15
16

Section 8:
5. The electronic prescription requirement provided for in this
16
17

Section 9:
section shall not apply to prescriptions for controlled dangerous
17
18
substances issued by any of the following:
18
19
a. a person licensed to practice veterinary medicine,
19
20
b. a practitioner who experiences temporary technological
20
21
or electrical failure or other extenuating
21
22
circumstance that prevents the prescription from being
22
23
transmitted electronically; provided, however, that
23
24
24
Req. No. 130 Page 2
1
the practitioner documents the reason for this
1
2
exception in the medical record of the patient,
2
3
c. a practitioner, other than a pharmacist, who dispenses
3
4
directly to an ultimate user,
4
5
d. a practitioner who orders a controlled dangerous
5
6
substance to be administered through an on-site
6
7
pharmacy in:
7
8
(1) a hospital as defined in Section 1-701 of this
8
9
title,
9
10
(2) a nursing facility as defined in Section 1-1902
10
11
of this title,
11
12
(3) a hospice inpatient facility as defined in
12
13

Section 10:
Section 1-860.2 of this title,
13
14
(4) an outpatient dialysis facility,
14
15
(5) a continuum of care facility as defined in
15
16

Section 11:
Section 1-890.2 of this title, or
16
17
(6) a penal institution listed in Section 509 of
17
18
Title 57 of the Oklahoma Statutes,
18
19
e. a practitioner who orders a controlled dangerous
19
20
substance to be administered through a hospice program
20
21
including, but not limited to, a hospice program that
21
22
provides hospice services in the private residence of
22
23
a patient or in a long-term care facility where the
23
24
patient resides. As used in this subparagraph,
24
Req. No. 130 Page 3
1
“hospice program” has the same meaning as provided by
1
2

Section 12:
Section 1-860.2 of this title,
2
3
f. a practitioner who writes a prescription to be
3
4
dispensed by a pharmacy located on federal property,
4
5
provided the practitioner documents the reason for
5
6
this exception in the medical record of the patient,
6
7
g. a practitioner that has received a waiver or extension
7
8
from his or her licensing board,
8
9
h. a practitioner who prescribes a controlled dangerous
9
10
substance for a supply that when taken as prescribed
10
11
would be consumed within seventy-two (72) hours, or
11
12
i. a practitioner who determines that an electronic
12
13
prescription cannot be issued in a timely manner and
13
14
the condition of the patient is at risk, or
14
15
j a practitioner who practices exclusively in one or
15
16
more medically underserved areas (MUAs) as designated
16
17
by the Health Resources and Services Administration.
17
18
This exemption shall not be available to a
18
19
practitioner who has been subject to disciplinary
19
20
action by the practitioner’s licensing board for a
20
21
violation related to the prescription of controlled
21
22
dangerous substances. The licensing board shall
22
23
communicate with and share necessary information with
23
24
the Oklahoma State Bureau of Narcotics and Dangerous
24
Req. No. 130 Page 4
1
Drugs Control for the purpose of enforcement of this
1
2
subparagraph.
2
3

Section 13:
6. Electronic prescriptions may be utilized under the following
3
4
circumstances:
4
5
a. compounded prescriptions,
5
6
b. compounded infusion prescriptions, or
6
7
c. prescriptions issued under approved research
7
8
protocols.
8
9

Section 14:
7. A pharmacist who receives a written, oral or facsimile
9
10
prescription shall not be required to verify that the prescription
10
11
falls under one of the exceptions provided for in paragraph 6 of
11
12
this subsection. Pharmacists may continue to dispense medications
12
13
from otherwise valid written, oral or facsimile prescriptions that
13
14
are consistent with the provisions of this section.
14
15

Section 15:
8. Practitioners shall indicate in the health record of a
15
16
patient that an exception to the electronic prescription requirement
16
17
was utilized.
17
18

Section 16:
9. All prescriptions issued pursuant to paragraph 5 and
18
19
subparagraph c of paragraph 6 of this subsection shall be on an
19
20
official prescription form approved by the Oklahoma State Bureau of
20
21
Narcotics and Dangerous Drugs Control if not issued electronically.
21
22

Section 17:
10. a. Practitioners shall be registered with the Oklahoma
22
23
State Bureau of Narcotics and Dangerous Drugs Control
23
24
in order to purchase official prescription forms.
24
Req. No. 130 Page 5
1
Such registration shall include, but not be limited
1
2
to, the primary address and the address of each place
2
3
of business to be imprinted on official prescription
3
4
forms. Any change to a registered practitioner’s
4
5
registered address shall be promptly reported to the
5
6
practitioner’s licensing board and the Bureau by the
6
7
practitioner in a manner approved by the Bureau.
7
8
b. Where the Bureau has revoked the registration of a
8
9
registered practitioner, the Bureau may revoke or
9
10
cancel any official prescription forms in the
10
11
possession of the registered practitioner. Any
11
12
revocation or any suspension shall require the
12
13
registered practitioner to return all unused official
13
14
prescription forms to the Bureau within fifteen (15)
14
15
calendar days after the date of the written
15
16
notification.
16
17
c. A practitioner that has had any license to practice
17
18
terminated, revoked or suspended by a state or federal
18
19
agency may, upon restoration of such license or
19
20
certificate, register with the Bureau.
20
21

Section 18:
11. a. Official prescription forms shall be purchased at the
21
22
expense of the practitioner or the employer of the
22
23
practitioner from a list of vendors approved by the
23
24
Bureau.
24
Req. No. 130 Page 6
1
b. Official prescription forms issued to a registered
1
2
practitioner shall be imprinted with the primary
2
3
address and may include other addresses listed on the
3
4
registration of the practitioner to identify the place
4
5
of origin. Such prescriptions shall be sent only to
5
6
the primary address of the registered practitioner.
6
7
c. Official prescription forms of a registered
7
8
practitioner shall be used only by the practitioner
8
9
designated on the official prescription form.
9
10
d. The Bureau may revoke or cancel official prescription
10
11
forms in the possession of a registered practitioners
11
12
practitioner when the license of such practitioner is
12
13
suspended, terminated or revoked.
13
14
e. Official prescription forms of registered
14
15
practitioners who are deceased or who no longer
15
16
prescribe shall be returned to the Bureau at a
16
17
designated address. If the registered practitioner is
17
18
deceased, it is the responsibility of the registered
18
19
practitioner’s estate or lawful designee to return
19
20
such forms.
20
21
f. The Bureau may issue official prescription forms to
21
22
employees or agents of the Bureau and other government
22
23
agencies for the purpose of preventing, identifying,
23
24
investigating and prosecuting unacceptable or illegal
24
Req. No. 130 Page 7
1
practices by providers and other persons and assisting
1
2
in the recovery of overpayments under any program
2
3
operated by the state or paid for with state funds.
3
4
Such prescription forms shall be issued for this
4
5
purpose only to individuals who are authorized to
5
6
conduct investigations on behalf of the Bureau or
6
7
other government agencies as part of their official
7
8
duties. Individuals and agencies receiving such
8
9
prescription forms for this purpose shall provide
9
10
appropriate assurances to the Bureau that adequate
10
11
safeguards and security measures are in place to
11
12
prevent the use of such prescription forms for
12
13
anything other than official government purposes.
13
14

Section 19:
12. a. Adequate safeguards and security measures shall be
14
15
undertaken by registered practitioners holding
15
16
official prescription forms to assure against the
16
17
loss, destruction, theft or unauthorized use of the
17
18
forms. Registered practitioners shall maintain a
18
19
sufficient but not excessive supply of such forms in
19
20
reserve.
20
21
b. Registered practitioners shall immediately notify the
21
22
Bureau, in a manner designated by the Bureau, upon
22
23
their knowledge of the loss, destruction, theft or
23
24
unauthorized use of any official prescription forms
24
Req. No. 130 Page 8
1
issued to them, as well as the failure to receive
1
2
official prescription forms within a reasonable time
2
3
after ordering them from the Bureau.
3
4
c. Registered practitioners shall immediately notify the
4
5
Bureau upon their knowledge of any diversion or
5
6
suspected diversion of drugs pursuant to the loss,
6
7
theft or unauthorized use of prescriptions.
7
8
B. 1. Except for dosages medically required for a period not
8
9
to exceed seventy-two (72) hours which are administered by or on
9
10
direction of a practitioner other than a pharmacist or medication
10
11
dispensed directly by a practitioner, other than a pharmacist, to an
11
12
ultimate user, or the circumstances provided for in paragraphs 5 and
12
13
6 of subsection A of this section, no controlled dangerous substance
13
14
included in Schedule III or IV, which is a prescription drug as
14
15
determined under regulation promulgated by the State Board of
15
16
Pharmacy, shall be dispensed without an electronic prescription.
16
17

Section 20:
2. Any prescription for a controlled dangerous substance in
17
18
Schedule III, IV or V may not be filled or refilled more than six
18
19
(6) months after the date thereof or be refilled more than five
19
20
times after the date of the prescription, unless renewed by the
20
21
practitioner.
21
22
C. Whenever it appears to the Director of the Oklahoma State
22
23
Bureau of Narcotics and Dangerous Drugs Control that a drug not
23
24
considered to be a prescription drug under existing state law or
24
Req. No. 130 Page 9
1
regulation of the State Board of Pharmacy should be so considered
1
2
because of its abuse potential, the Director shall so advise the
2
3
State Board of Pharmacy and furnish to the Board all available data
3
4
relevant thereto.
4
5
D. 1. “Prescription”, as used in this section, means a
5
6
written, oral or electronic order by a practitioner to a pharmacist
6
7
for a controlled dangerous substance for a particular patient, which
7
8
specifies the date of its issue, and the full name and address of
8
9
the patient and, if the controlled dangerous substance is prescribed
9
10
for an animal, the species of the animal, the name and quantity of
10
11
the controlled dangerous substance prescribed, the directions for
11
12
use, the name and address of the owner of the animal and, if
12
13
written, the signature of the practitioner. When electronically
13
14
prescribed, the full name of the patient may include the name and
14
15
species of the animal.
15
16

Section 21:
2. “Registered practitioner”, as used in this section, means a
16
17
licensed practitioner duly registered with the Oklahoma State Bureau
17
18
of Narcotics and Dangerous Drugs Control authorized to purchase
18
19
official prescription forms.
19
20
E. No person shall solicit, dispense, receive or deliver any
20
21
controlled dangerous substance through the mail, unless the ultimate
21
22
user is personally known to the practitioner and circumstances
22
23
clearly indicate such method of delivery is in the best interest of
23
24
the health and welfare of the ultimate user.
24
Req. No. 130 Page 10
1

Section 22:
SECTION 2. This act shall become effective November 1, 2025.
1
2
2
3
60-1-130 DC 12/16/2024 10:49:16 AM
3
4
4
5
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 130 Page 11
[DELETED:  P B B]
[DELETED:  P a a]
[DELETED:  P a a a a a a a a a]
[DELETED:  P a a a a a]
[DELETED:  P c c p a P]
[DELETED:  P W A a O]
[DELETED:  P O O T O T]
[DELETED:  P a A R]
[DELETED:  P R]
[DELETED:  P]
[DELETED:  P D 1]


================================================================================

Raw Text:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 27 By: Bullard
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to controlled dangerous substances;
7
amending 63 O.S. 2021, Section 2-309, as last amended
8
by Section 6, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
8
2024, Section 2-309), which relates to prescriptions;
9
exempting certain practitioners from electronic
9
prescription requirement; limiting availability of
10
exemption; directing licensing boards to take certain
10
actions; updating statutory language; and providing
11
an effective date.
11
12
12
13
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
13
14
SECTION 1. AMENDATORY 63 O.S. 2021, Section 2-309, as
14
15
last amended by Section 6, Chapter 308, O.S.L. 2024 (63 O.S. Supp.
15
16
2024, Section 2-309), is amended to read as follows:
16
17
Section 2-309. A. 1. Except for dosages medically required
17
18
for a period not to exceed forty-eight (48) hours which are
18
19
administered by or on direction of a practitioner, other than a
19
20
pharmacist, or medication dispensed directly by a practitioner,
20
21
other than a pharmacist, to an ultimate user, no controlled
21
22
dangerous substance included in Schedule II, which is a prescription
22
23
drug as determined under regulation promulgated by the State Board
23
24
of Pharmacy, shall be dispensed without an electronic prescription
24
Req. No. 130 Page 1

1
of a practitioner; provided, that in emergency situations, as
1
2
prescribed by the State Board of Pharmacy by regulation, such drug
2
3
may be dispensed upon oral prescription reduced promptly to writing
3
4
and filed by the pharmacist in a manner to be prescribed by rules
4
5
and regulations of the Director of the Oklahoma State Bureau of
5
6
Narcotics and Dangerous Drugs Control.
6
7
2. Electronic prescribing shall be utilized for Schedules II,
7
8
III, IV and V, subject to the requirements set forth in 21 CFR,
8
9
Section 1311 et seq.
9
10
3. An electronic prescription with electronic signature may
10
11
serve as an original prescription, subject to the requirements set
11
12
forth in 21 CFR, Section 1311 et seq.
12
13
4. Prescriptions shall be retained in conformity with the
13
14
requirements of this section and Section 2-307 of this title. No
14
15
prescription for a Schedule II substance may be refilled.
15
16
5. The electronic prescription requirement provided for in this
16
17
section shall not apply to prescriptions for controlled dangerous
17
18
substances issued by any of the following:
18
19
a. a person licensed to practice veterinary medicine,
19
20
b. a practitioner who experiences temporary technological
20
21
or electrical failure or other extenuating
21
22
circumstance that prevents the prescription from being
22
23
transmitted electronically; provided, however, that
23
24
24
Req. No. 130 Page 2

1
the practitioner documents the reason for this
1
2
exception in the medical record of the patient,
2
3
c. a practitioner, other than a pharmacist, who dispenses
3
4
directly to an ultimate user,
4
5
d. a practitioner who orders a controlled dangerous
5
6
substance to be administered through an on-site
6
7
pharmacy in:
7
8
(1) a hospital as defined in Section 1-701 of this
8
9
title,
9
10
(2) a nursing facility as defined in Section 1-1902
10
11
of this title,
11
12
(3) a hospice inpatient facility as defined in
12
13
Section 1-860.2 of this title,
13
14
(4) an outpatient dialysis facility,
14
15
(5) a continuum of care facility as defined in
15
16
Section 1-890.2 of this title, or
16
17
(6) a penal institution listed in Section 509 of
17
18
Title 57 of the Oklahoma Statutes,
18
19
e. a practitioner who orders a controlled dangerous
19
20
substance to be administered through a hospice program
20
21
including, but not limited to, a hospice program that
21
22
provides hospice services in the private residence of
22
23
a patient or in a long-term care facility where the
23
24
patient resides. As used in this subparagraph,
24
Req. No. 130 Page 3

1
“hospice program” has the same meaning as provided by
1
2
Section 1-860.2 of this title,
2
3
f. a practitioner who writes a prescription to be
3
4
dispensed by a pharmacy located on federal property,
4
5
provided the practitioner documents the reason for
5
6
this exception in the medical record of the patient,
6
7
g. a practitioner that has received a waiver or extension
7
8
from his or her licensing board,
8
9
h. a practitioner who prescribes a controlled dangerous
9
10
substance for a supply that when taken as prescribed
10
11
would be consumed within seventy-two (72) hours, or
11
12
i. a practitioner who determines that an electronic
12
13
prescription cannot be issued in a timely manner and
13
14
the condition of the patient is at risk, or
14
15
j a practitioner who practices exclusively in one or
15
16
more medically underserved areas (MUAs) as designated
16
17
by the Health Resources and Services Administration.
17
18
This exemption shall not be available to a
18
19
practitioner who has been subject to disciplinary
19
20
action by the practitioner’s licensing board for a
20
21
violation related to the prescription of controlled
21
22
dangerous substances. The licensing board shall
22
23
communicate with and share necessary information with
23
24
the Oklahoma State Bureau of Narcotics and Dangerous
24
Req. No. 130 Page 4

1
Drugs Control for the purpose of enforcement of this
1
2
subparagraph.
2
3
6. Electronic prescriptions may be utilized under the following
3
4
circumstances:
4
5
a. compounded prescriptions,
5
6
b. compounded infusion prescriptions, or
6
7
c. prescriptions issued under approved research
7
8
protocols.
8
9
7. A pharmacist who receives a written, oral or facsimile
9
10
prescription shall not be required to verify that the prescription
10
11
falls under one of the exceptions provided for in paragraph 6 of
11
12
this subsection. Pharmacists may continue to dispense medications
12
13
from otherwise valid written, oral or facsimile prescriptions that
13
14
are consistent with the provisions of this section.
14
15
8. Practitioners shall indicate in the health record of a
15
16
patient that an exception to the electronic prescription requirement
16
17
was utilized.
17
18
9. All prescriptions issued pursuant to paragraph 5 and
18
19
subparagraph c of paragraph 6 of this subsection shall be on an
19
20
official prescription form approved by the Oklahoma State Bureau of
20
21
Narcotics and Dangerous Drugs Control if not issued electronically.
21
22
10. a. Practitioners shall be registered with the Oklahoma
22
23
State Bureau of Narcotics and Dangerous Drugs Control
23
24
in order to purchase official prescription forms.
24
Req. No. 130 Page 5

1
Such registration shall include, but not be limited
1
2
to, the primary address and the address of each place
2
3
of business to be imprinted on official prescription
3
4
forms. Any change to a registered practitioner’s
4
5
registered address shall be promptly reported to the
5
6
practitioner’s licensing board and the Bureau by the
6
7
practitioner in a manner approved by the Bureau.
7
8
b. Where the Bureau has revoked the registration of a
8
9
registered practitioner, the Bureau may revoke or
9
10
cancel any official prescription forms in the
10
11
possession of the registered practitioner. Any
11
12
revocation or any suspension shall require the
12
13
registered practitioner to return all unused official
13
14
prescription forms to the Bureau within fifteen (15)
14
15
calendar days after the date of the written
15
16
notification.
16
17
c. A practitioner that has had any license to practice
17
18
terminated, revoked or suspended by a state or federal
18
19
agency may, upon restoration of such license or
19
20
certificate, register with the Bureau.
20
21
11. a. Official prescription forms shall be purchased at the
21
22
expense of the practitioner or the employer of the
22
23
practitioner from a list of vendors approved by the
23
24
Bureau.
24
Req. No. 130 Page 6

1
b. Official prescription forms issued to a registered
1
2
practitioner shall be imprinted with the primary
2
3
address and may include other addresses listed on the
3
4
registration of the practitioner to identify the place
4
5
of origin. Such prescriptions shall be sent only to
5
6
the primary address of the registered practitioner.
6
7
c. Official prescription forms of a registered
7
8
practitioner shall be used only by the practitioner
8
9
designated on the official prescription form.
9
10
d. The Bureau may revoke or cancel official prescription
10
11
forms in the possession of a registered practitioners
11
12
practitioner when the license of such practitioner is
12
13
suspended, terminated or revoked.
13
14
e. Official prescription forms of registered
14
15
practitioners who are deceased or who no longer
15
16
prescribe shall be returned to the Bureau at a
16
17
designated address. If the registered practitioner is
17
18
deceased, it is the responsibility of the registered
18
19
practitioner’s estate or lawful designee to return
19
20
such forms.
20
21
f. The Bureau may issue official prescription forms to
21
22
employees or agents of the Bureau and other government
22
23
agencies for the purpose of preventing, identifying,
23
24
investigating and prosecuting unacceptable or illegal
24
Req. No. 130 Page 7

1
practices by providers and other persons and assisting
1
2
in the recovery of overpayments under any program
2
3
operated by the state or paid for with state funds.
3
4
Such prescription forms shall be issued for this
4
5
purpose only to individuals who are authorized to
5
6
conduct investigations on behalf of the Bureau or
6
7
other government agencies as part of their official
7
8
duties. Individuals and agencies receiving such
8
9
prescription forms for this purpose shall provide
9
10
appropriate assurances to the Bureau that adequate
10
11
safeguards and security measures are in place to
11
12
prevent the use of such prescription forms for
12
13
anything other than official government purposes.
13
14
12. a. Adequate safeguards and security measures shall be
14
15
undertaken by registered practitioners holding
15
16
official prescription forms to assure against the
16
17
loss, destruction, theft or unauthorized use of the
17
18
forms. Registered practitioners shall maintain a
18
19
sufficient but not excessive supply of such forms in
19
20
reserve.
20
21
b. Registered practitioners shall immediately notify the
21
22
Bureau, in a manner designated by the Bureau, upon
22
23
their knowledge of the loss, destruction, theft or
23
24
unauthorized use of any official prescription forms
24
Req. No. 130 Page 8

1
issued to them, as well as the failure to receive
1
2
official prescription forms within a reasonable time
2
3
after ordering them from the Bureau.
3
4
c. Registered practitioners shall immediately notify the
4
5
Bureau upon their knowledge of any diversion or
5
6
suspected diversion of drugs pursuant to the loss,
6
7
theft or unauthorized use of prescriptions.
7
8
B. 1. Except for dosages medically required for a period not
8
9
to exceed seventy-two (72) hours which are administered by or on
9
10
direction of a practitioner other than a pharmacist or medication
10
11
dispensed directly by a practitioner, other than a pharmacist, to an
11
12
ultimate user, or the circumstances provided for in paragraphs 5 and
12
13
6 of subsection A of this section, no controlled dangerous substance
13
14
included in Schedule III or IV, which is a prescription drug as
14
15
determined under regulation promulgated by the State Board of
15
16
Pharmacy, shall be dispensed without an electronic prescription.
16
17
2. Any prescription for a controlled dangerous substance in
17
18
Schedule III, IV or V may not be filled or refilled more than six
18
19
(6) months after the date thereof or be refilled more than five
19
20
times after the date of the prescription, unless renewed by the
20
21
practitioner.
21
22
C. Whenever it appears to the Director of the Oklahoma State
22
23
Bureau of Narcotics and Dangerous Drugs Control that a drug not
23
24
considered to be a prescription drug under existing state law or
24
Req. No. 130 Page 9

1
regulation of the State Board of Pharmacy should be so considered
1
2
because of its abuse potential, the Director shall so advise the
2
3
State Board of Pharmacy and furnish to the Board all available data
3
4
relevant thereto.
4
5
D. 1. “Prescription”, as used in this section, means a
5
6
written, oral or electronic order by a practitioner to a pharmacist
6
7
for a controlled dangerous substance for a particular patient, which
7
8
specifies the date of its issue, and the full name and address of
8
9
the patient and, if the controlled dangerous substance is prescribed
9
10
for an animal, the species of the animal, the name and quantity of
10
11
the controlled dangerous substance prescribed, the directions for
11
12
use, the name and address of the owner of the animal and, if
12
13
written, the signature of the practitioner. When electronically
13
14
prescribed, the full name of the patient may include the name and
14
15
species of the animal.
15
16
2. “Registered practitioner”, as used in this section, means a
16
17
licensed practitioner duly registered with the Oklahoma State Bureau
17
18
of Narcotics and Dangerous Drugs Control authorized to purchase
18
19
official prescription forms.
19
20
E. No person shall solicit, dispense, receive or deliver any
20
21
controlled dangerous substance through the mail, unless the ultimate
21
22
user is personally known to the practitioner and circumstances
22
23
clearly indicate such method of delivery is in the best interest of
23
24
the health and welfare of the ultimate user.
24
Req. No. 130 Page 10

1
SECTION 2. This act shall become effective November 1, 2025.
1
2
2
3
60-1-130 DC 12/16/2024 10:49:16 AM
3
4
4
5
5
6
6
7
7
8
8
9
9
10
10
11
11
12
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 130 Page 11

[DELETED:  P B B]
[DELETED:  P a a]
[DELETED:  P a a a a a a a a a]
[DELETED:  P a a a a a]
[DELETED:  P c c p a P]
[DELETED:  P W A a O]
[DELETED:  P O O T O T]
[DELETED:  P a A R]
[DELETED:  P R]
[DELETED:  P]
[DELETED:  P D 1]